Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Initial_Public_Offering
|
| gptkbp:date |
2016-02-03
|
| gptkbp:focus |
gene editing
|
| gptkbp:hasCompany |
gptkb:Editas_Medicine
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:offeredBy |
$16 per share
|
| gptkbp:offers |
5.9 million
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
EDIT
|
| gptkbp:totalRaised |
$94.4 million
|
| gptkbp:bfsParent |
gptkb:Atlas_Venture
gptkb:ARCH_Venture_Partners |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Editas Medicine IPO
|